Abstract: A compound comprising a first ligand LA of Formula I, is provided. In the compound, X1 and X2 are C or N; YA and YC is each single atom bridges, which can be substituted; each RA, RB, and RC is a hydrogen or a General Substituent defined herein; LA is coordinated to a metal M, and LA may be joined with other ligands; and any two substituents may be joined or fused to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound of formula Ir(LA)x(LB)y(LC)z, where x and y are 1 or 2; z is 0 or 1; and x+y+z=3. In the compound, LA comprises Formula I, ligand LB comprises Formula II, and ligand LC is a bidentate ligand. In Formulas I and II, moiety A is a monocyclic ring or a polycyclic fused ring system; each of X1 to X14 is C or N; Y is a linking group; each R1-R2, R, R?, and RA-RE is hydrogen or a General Substituent defined herein; at least one of R1 and R2 is a tertiary alkyl group; and (1) at least one pair of RB or RC substituents are joined or fused to form a ring, or (2) at least one RC or RB comprises an electron-withdrawing group other than nitrile, or (3) X11 is N, R1 is a tertiary alkyl group. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, each of X1 to X6 is C or N; K is a direct bond or a linker; each of L1 and L2 is a linker; each R, R?, R?, R?, RA, and RB is hydrogen or a General Substituent defined herein; two RB are joined to form a ring; LA is coordinated to a metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound having a first ligand LA including a structure of Formula I: In Formula I, ring A is 5-membered heterocyclic ring; each of Z1, Z2, and X1 to X5 is C or N; Y is a linking group; K is a direct bond or a linking group; RZ is a General Substituent defined herein; each other substituent is hydrogen or a General Substituent defined herein; and (1) two RC substituents are joined together to form a ring, or (2) the compound comprises an electron-withdrawing group. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A composition is disclosed that includes a first compound capable of functioning as a host in an emissive layer of an OLED at room temperature; and a second compound that includes a ligand LA of Formula III where ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; where R represents two adjacent substituents that are joined together to form a ring that is fused to ring B, and R has a structure of Formula IV or Formula V disclosed herein.

Abstract: Provided are a compound having a metal M and a first ligand LA comprising the structure of where the compound is capable of functioning as a phosphorescent emitter in an organic light emitting device at room temperature.

Abstract: A compound comprising a ligand LA of Formula I coordinated to a metal M as represented by the dotted lines wherein ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring, and ring B is a multicyclic ring system comprising four to eight fused 5-membered or 6-membered, carbocyclic or heterocyclic rings; wherein the ring B includes a structure of Formula II wherein ring C is a 5-membered or 6-membered carbocyclic or heterocyclic ring, and the dotted lines of Formula II represent fusion of the structure of Formula II as part of the multicyclic ring system of ring B; T1, T2, and T3 are independently selected from N or C; and L is a linker L2-L1 with L2 and L1 independently selected from the group consisting of O, S, NRN, CR1R2, CR3R4, SiR1R2, and SiR3R4; wherein at least one of L1 or L2 is CR1CR2 or SiR1R2; and the metal M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Pd, Au, and Cu.

Abstract: A compound comprising a first ligand LA of Formula I, is provided, where: each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system; each of X1 to X4 and Z1 and Z2 is C or N; K1 and K2 are each a direct bond or a linker; L1 is a direct bond or an organic linker; each R?, R?, RA and RB is hydrogen or a General Substituent defined herein; and at least one RA or one RB comprises R*, where R* is an alkyl group, a silyl group, a germyl group, or a combination thereof. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are organometallic compounds which comprise a ligand comprising a 6-membered aromatic carbocyclic or heterocyclic ring which is bond via a direct bond to a moiety which is a monocyclic 5-membered or 6-membered carbocyclic or heterocyclic ring or a polycyclic fused ring system comprising two or more 5-membered or 6-membered carbocyclic or heterocyclic rings. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are compounds having a first ligand LA of that are useful in OLEDs as emitters.

Abstract: An OLED including an organic layer that contains metal complex compounds that are useful as a phosphorescent emitter is disclosed. The metal complex compounds include ligands that incorporate fluorinated side chains and has at least one substituent R selected from the group consisting of partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof, wherein R is directly bonded to an aromatic ring, In the compound, C having an F attached thereto is separated by at least one carbon atom from the aromatic ring.

Abstract: A compound of Formula Ir(LA)p(LB)q(LC)r is provided, where ligand LA has a structure of Formula I, LB and LC are bidentate ligands; p is 1 or 2; the compound is heteroleptic; moieties A, B, and C are each monocyclic rings or polycyclic fused ring systems; Z1 and Z2 are C or N; K is a direct bond or a linker; each RA, RB, RC, or other R variable is hydrogen or a General Substituents defined herein; and any two substituents may be joined or fused to form a ring.

Abstract: Provided are compounds having a ligand LA of Formula I that are useful as emissive compounds in organic light emitting devices.

Abstract: Provided are organometallic compounds comprising a ligand which contains at least one group of three 5-membered or 6-membered carbocyclic or heterocyclic rings which are fused together so that they all share one central C or N atom. Also provided are formulations comprising these organometallic compounds. Further provided are organic light-emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic compounds comprising two moieties A and B which are each independently a monocyclic ring or a polycyclic fused ring structure, wherein the monocyclic ring or each ring of the polycyclic fused ring structure is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring which are linked by a direct bond and which are further bridged by a linker comprising two groups which are each independently selected from the group consisting of O, S, Se, NR, BR, BRR?, PR, CR, C?O, C?NR, C?CRR?, C?S, CRR?, SO, SO2, P(O)R, SiRR?, and GeRR?. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: A compound having a structure of Formula I, is provided. In Formula I, X1-X7, Z1 and Z2 are each independently C or N; Z3 is selected from BR?, NR?, PR?, O, S, Se, C?O, S?O, SO2, CR?R?, SiR?R?, and GeRR?; L is selected from O, S, and NR; C1, C2, and C3 are all carbon atoms; the bonds represent single bond or double bond to fulfill the valency requirement of a neutral compound; each R1, R2, R3, R, R?, R?, RA, and RB is independently hydrogen or a substituent; and any two of R1, R2, R3, R, R?, R?, RA, and RB can be joined or fused together to form a ring. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound comprising a hexadentate ligand of Formula I coordinated to a metal selected from the group consisting of iridium, rhodium, and osmium; wherein rings A, B, C, D, E, and F are independently a 5-membered or 6-membered heteroaryl ring, or a 6-membered aryl ring; T1, T2, T3, T4, T5, and T6 are independently selected from C or N, wherein two to four of T1 to T6 are C, and two to four of T1 to T6 are N; Z1, Z2, Z3, and Z4 are independently selected from C or N, wherein if Z1 and Z2 are each N then T1 is a carbene carbon and two of T2 to T6 are N; Y1 and Y2 are independently selected from the group consisting of CR, SiR, B, or N; W1-W7 are independently selected from the group consisting of a direct bond, BR, BRR?, NR, PR, O, S, Se, C?X, S?O, SO2, CR, CRR?, SiRR?, GeRR?, alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; wherein X is selected from the group consisting of O, S, Se, NR?, and CR?R??; RA to RF independently represent mono to the maximum allowable substitution, or no substitu

Abstract: Provided are novel silyl-containing acetylacetonate derivatives compounds. Also provided are formulations comprising these silyl-containing acetylacetonate derivatives compounds. Further provided are OLEDs and related consumer products that utilize these silyl-containing acetylacetonate derivatives compounds.

Abstract: A compound comprising a first bidentate ligand LA, wherein LA comprises a structure of Formula I; wherein Z is selected from the group consisting of O, S, NR, BR, CRKRL, SiRKRL, —CRKRLCRMRN—, —SiRKRLSiRMRN—, —CRKRLO—, —SiRKRLO—, and —CRK?CRL—; wherein ring A, ring B, and ring C are each independently a 5-membered carbocyclic ring, 5-membered heterocyclic ring, 6-membered carbocyclic ring or 6-membered heterocyclic ring; wherein LA is coordinated to a metal M forming a 5-membered chelate ring; wherein M is selected from the group consisting of Ir, Pt, Pd, Ru, Rh, Os, Re, Cu, Ag, and Au; wherein RA, RB, and RC each represent mono to the maximum allowable substitution, or no substitution; wherein each R, RK, RL, RM, RN, RA, RB, and RC is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, car